Psychedelic drugs may be ready for a medical comeback

New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community, says a new analysis in the Canadian Medical Assn. Journal.

For several decades, the North American medical establishment has classified psychedelic drugs -- including lysergic acid diethylamide (LSD), psilocybin and methylenedioxymethamphetamine (MDMA) -- as drugs of abuse with little to no medical purpose or means of safe use.